Biocon Biologics to Acquire Viatris’ biosimilar assets
New Delhi, Feb 28 (IANS) Biocon Biologics on Monday said it will acquire Viatris global biosimilars business including their rights in partnered in-licensed portfolio.The company is making the acquisition for up to $3.335 billion in stock…